Exploit Technologies cordially invites you to IP STRATEGY FOR MEDICAL DEVICE PRODUCTS: VentureMD’s Approach on Friday, 3 August 2012. As seating is limited, please register early to avoid disappointment.
Our invited speaker is Dr Casey Chan.
Dr Casey Chan has over 25 years of experience as an orthopedic surgeon, inventor, researcher and entrepreneur. He has brought a number of innovations from concept to the standard of surgical care, including a vacuum mixing system for total joint replacements and a suture passer for arthroscopic surgery.
He is currently an Adjunct Professor at the National University of Singapore (NUS), with appointments at the Department of Orthopaedic Surgery and the Division of Bioengineering, a Fellow of the American Academy of Orthopedic Surgeons and a Fellow of the Canadian Academy of Sport Medicine. His previous experience as the Director of Technology Transfer Office and as the Senior Director of NUS Enterprise at the National University of Singapore (NUS) provides Dr Chan with unique executive and management skills.
Dr Chan is also on the governing board of the Mechanobiology Research Center of Excellence, Singapore and teaches a course on Bioengineering Design for third-year Bioengineering students at NUS. He holds a Master’s Degree of Applied Science in Aerospace Engineering from the University of Toronto, a Doctor of Medicine degree from the University of Toronto, completed orthopedic surgery training at the University of Toronto Residency Program and completed a spine fellowship under Dr Ian MacNab. His research interests lie in the area of tissue engineering and the effects of nanotexture on stem cell differentiations. He has been published in over 50 peer-reviewed publications and currently holds over 40 issued U.S. patents, with more patents pending.
A strong IP portfolio cannot be developed overnight. It requires appropriate allocation of resources, including budget, manpower and stakeholders’ interests. Having wide or early IP protection may strain resources that could be better allocated to other operational areas while narrow or late IP protection raises issues of competition and results in weak market control that adversely impacts a company’s business.
VentureMD is a medical device incubator based in the US providing human, financial and intellectual capital to develop and manage start-up medical companies. Integral to VentureMD's product and business development process is a solid IP strategy. This includes:
• Critical involvement from management, technical staff and business development executives
• Understanding the different barriers of entry to Class I, II and III devices
• Making the right decision to file based on product coverage rather than perceived technology performance
This talk aims to provide an insight into the successful internal processes of VentureMD’s IP strategy as well as a better understanding of developing a strong IP portfolio from an investor’s perspective.
VentureMD is an angel capital firm and medical device incubator focused on musculoskeletal products. They provide human, financial, and intellectual capital to develop and manage start-up medical device companies around promising ideas. Focusing on developing the best ideas into the best companies, VentureMD serves the areas of orthopedics, spine, dental, arthroscopy and laparoscopy.